Overview

Study of Bleeding With Extended Administration of an Oral Contraceptive

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.
Phase:
Phase 2
Details
Lead Sponsor:
Warner Chilcott
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Norethindrone
Norethindrone Acetate
Polyestradiol phosphate